Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysis

Coronary Artery Disease

Volumn 9, Issue 7, 1998, Pages 451-456

  Gurbel, Paul A ^a   Serebruany, Victor L ^a   Shustov, Andrew R ^a   Dalesandro, Margaret ^b   Gumbs, Cindy I ^b   Grablutz, Laura B ^b   Bahr, Raymond D ^c   Ohman, E Magnus ^d   Topol, Eric J ^e  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b CENTOCOR INC   (United States)

^c ST AGNES HOSPITAL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute myocardial infarction; Flow cytometry; Human; Platelet aggregation; Platelet receptors; Thrombolysis

Indexed keywords

CD31 ANTIGEN; FIBRINOLYTIC AGENT; PADGEM PROTEIN; THROMBOCYTE RECEPTOR;

ACUTE HEART INFARCTION; ADULT; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HUMAN; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TREATMENT FAILURE;

EID: 0031761263     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809070-00008     Document Type: Article

References (34)

1. Eccleston D, Topol EJ. Inhibitors of platelet IIb/IIIa as augmenters of thrombolysis. Coronary Artery Dis 1995; 6:947-955.
2. Davies MJ, Thomas AC, Knapman PA, Hangarter JR. Intramyocardial platelet aggregation in patients with acute myocardial infarction suffering sudden ischemic cardiac death. Circulation 1986; 73:418-427.
3. Luchessi BR, Rote WE, Driscoll EM, Mu DX. Prevention of thrombosis and rethrombosis and enhancement of thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist. Br J Pharmacol 1994; 113:1333-1343.
4. Nicolini FA, Lee P, Rios G, Kottke-Merchant K, Topol EJ. Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis. Circulation 1994; 89:1802-1809.
5. Roux SP, Tschopp TB, Kuhn H, Steiner B, Hadvary P. Effects of heparin, aspirin and synthetic platelet glycoprotein IIb/IIIA receptor antagonist on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog. J Pharmacol Exp Ther 1993; 264:501-508.
6. Torr SR, Winters KJ, Santoro SA, Sobel BE. The nature of interactions between tissue-type plasminogen activators and platelets. Thromb Res 1990; 59:279-293.
7. Golino P, Ashton JH, Glas-Greenwalt P, McNatt J, Buja LM, Willerson JT. Mediation of reocclusion by thromboxane with tissue type plasminogen activator in a canine preparation of coronary thrombosis. Circulation 1988; 77:678-684.
8. Fitzgerald DJ, Catella F, Roy L, Fitzgerald GA. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 1988; 77:142-150.
9. Frandsen NJ, Winther K, Pedersen F, Christiansen I, McNair P. Time course of platelet a granule release in acute myocardial infarction treated with streptokinase. Heart 1996; 75:141-144.
10. Barbagelata A, Gragner CB, Topol EJ, Worley SJ, Kereiakes DJ, George BS, et al. Frequency, significance and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1995; 76:1007-1013.
11. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329:673-682.
12. Ault KA. Flow cytometric measurement of platelet function and reticulated platelets. Ann NY Acad Sci 1993; 677:293-308.
13. Serebruany VL, Ordonez JV, Herzog WR, Rohde M, Mortensen SA, Folkers K, et al. Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression. J Cardiovasc Pharmacol 1997; 29:16-22.
14. Gurbel PA, Navetta FI, Bates ER, Muller DW, Tenaglia AN, Miller MJ, et al. Lesion-directed administration of tissue plasminogen activator with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty. Cathet Cardiovasc Diagn 1996; 37: 382-391.
15. O'Connor CM, Meese RB, McNulty S, Lucas KD, Carney RJ, LeBoeuf RM, et al. A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. Am J Cardiol 1996; 77:791-797.
16. Becker RC, Bovill EG, Corrao JM, Ball SP, Ault K, Mann K, et al. Platelet activation determined by flow cytometry persists despite antithrombotic therapy in patients with unstable angina and non-Q-wave myocardial infarction. J Thromb Thrombol 1994; 1:95-100.
17. Trip MD, Cats VM, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990; 322:1549-1554.
18. De Lorgeril M, Boissonat P, Mamelle N, Martin JL, Monjaud I, Guidollet J, et al. Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients. Circulation 1994; 89:2590-2594.
19. Jang IK, Gold HK, Ziskind AA, Fallon JT, Holt RE, Leinbach RC, et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: a possible explanation for resistance to coronary thrombolysis. Circulation 1989; 79:920-928.
20. Gold HK, Garabedian HD, Dinsmore RE, Guerrero LJ, Cigarroa JE, Palacios IF, et al. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans. Circulation 1997; 95:1755-1759.
21. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332:635-641.
22. Pumphrey CW, Dawes J. Plasma beta-thromboglobulin as a measure of platelet activity. Effect of risk factors and findings in ischemic heart disease and after acute myocardial infarction. Am J Cardiol 1982; 50:1258-1261.
23. Hughes A, Daunt S, Vass G, Wickes J. In vivo platelet activation following myocardial infarction and acute coronary ischemia. Thromb Haemost 1982; 48:133-135.
24. Tedder TF, Steeber DA, Chen A, Engel P. The selectins: vascular adhesion molecules. FASEB J 1995; 9:866-873.
25. Weyrich AS, Ma XL, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993; 91:2620-2629.
26. Ueyama T, Ikeda H, Haramaki N, Kuwano K, Imaizumi T. Effects of monoclonal antibody to P-selectin and analogue of sialyl Lewis X on cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. Circulation 1997; 95:1554-1559.
27. Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995; 92:1693-1696.
28. Kaikita K, Ogawa H, Yasue H, Sakamoto T, Suefuji H, Sumida H, et al. Soluble P-selectin is released into the coronary circulation after coronary spasm. Circulation 1995; 92:1726-1730.
29. Ikeda H, Nakayama H, Oda T, Kuwano K, Muraishi A, Sugi K, et al. Soluble form of P-selectin in patients with acute myocardial infarction. Coronary Artery Dis 1994; 5:515-518.
30. Yusuf SW, Sanderson H, Heptinstall S, Nurden AT, Wenham PW, Hopkinson BR. ADP-induced P-selectin expression on platelets as a predictor of successful thrombolysis. Blood Coagul Fibrinol 1996; 7:266-269.
31. Lu J, Qi W, Shao H. Dynamic changes of the platelet granule membrane glycoprotein level in patients with acute myocardial infarction before and after thrombolysis. Chin J Intern Med 1995; 34:302-304.
32. Newman PJ, Berndt MC, Gorsky J, White GC, Paddock LS, Muller WA. PECAM-1 (CD 31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990; 247:1219-1223.
33. Muller WA, Berman ME, Newman PJ, DeLisser HM, Albelda SM. A heterophylic adhesion mechanisms for platelet/endothelial adhesion molecule 1 (CD 31). J Exp Med 1992; 175:1401-1404.
34. Anand S, Kudallur V, Pitman EB, Diamond SL Mechanisms by which thrombolytic therapy results in nonuniform lysis and residual thrombus after reperfusion. Ann Biomed Eng 1997; 25:964-974.